FIELD: medicine. SUBSTANCE: invention proposes the use of human fetal liver tissue suspension as an agent for hyperlipidemia correction. EFFECT: enhanced effectiveness of an agent. 3 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD TO CORRECT LIPID PEROXIDE OXIDATION IN PATIENTS SUFFERING ISCHEMIC CARDIAC DISEASE | 1999 |
|
RU2178704C2 |
| AGENT WITH HYPOLIPIDEMIC ACTIVITY | 2004 |
|
RU2268714C1 |
| METHOD FOR TREATING CHRONIC PERIODONTITIS | 1999 |
|
RU2161920C1 |
| MEDIUM FOR CONSERVATION OF SPLENIC CELLS | 2001 |
|
RU2194753C2 |
| METHOD OF DETERMINING INDICATIONS FOR PERFORMING EFFERENT THERAPY | 1996 |
|
RU2163018C2 |
| HYPOLIPIDEMIC AGENT | 2008 |
|
RU2392933C2 |
| METHOD FOR MODELING GASTRODUODENITIS ASSOCIATED WITH HYPERLIPEMIA | 1999 |
|
RU2195024C2 |
| METHOD OF TREATMENT OF PATIENTS WITH CALCULOUS CHOLECYSTITIS | 1997 |
|
RU2129026C1 |
| METHOD FOR AUTOTRANSPLANTATION OF SPLENIC TISSUES | 1994 |
|
RU2112429C1 |
| METHOD FOR PREPARING SKIN COVER DEFECT TO AUTODERMOPLASTY OPERATION | 2000 |
|
RU2192266C2 |
Authors
Dates
1998-06-10—Published
1995-07-20—Filed